Drugs / C. albicans antigen
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05652998 Comparator | Oct 2021 → Dec 2022 | plantar wart | South Valley University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C. albicans antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05652998 ↗ |
| Route | Other | “a test dose (0.1 ml) of the C. albicans antigen will be injected intradermally into the skin of the forearm.” NCT05652998 ↗ |